Stocks / NASDAQ / Keryx Biopharmaceuticals, Inc.

Keryx Biopharmaceuticals, Inc.

Our Opinion

Keryx Biopharmaceuticals, Inc. is on the Cruelty Free Investing list for exploiting animals because the company does animal testing for some of their medical analysis and clinical research.

Supporting Evidence:

The company stated in the following report that they conduct pre-clinical trials of their drugs on animals.

“Lower level tissue deposition, particularly in bone and liver, has been observed in animals.” (Page 13) Read the following article

Company Description

Keryx Biopharmaceuticals, Inc. engages in the development and commercialization of medicines for the treatment of renal disease. Its products include phosphate-binding medicines, intravenous iron, and other medications. The company was founded in October 1998 and is headquartered in Boston, MA. [Source: MarketWatch]

Company Website: